Exports fuel Analytik Jena's sales recovery
This article was originally published in Clinica
Analytik Jena, which manufactures analytical instrumentation technology for life sciences, biotechnology, environmental and energy technology, increased its sales by 10% during the first quarter of 2002-03. The Jena, Germany-based company said that domestic sales had fallen by 20.7% to E14.2m for the first quarter. Sales in the company's analytical solutions and bioanalytical solutions business units fell slightly to E6.3m, compared with E6.7m during the same period for 2001/-02. In contrast, exports more than tripled to E8.16, compared with E2.5m for the same period last year. It now makes more than a third of its sales outside Germany.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.